| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 2.14 | (18.86) | (7.27)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2.94 | (29.19) | (10.57)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 9.65 | (41.64) | (14.48)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 2.85 | (31.12) | (10.69)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.11 | (28.98) | (8.54)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | n/a | (25.84) | (5.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | n/a | (39.22) | (7.57)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Faridoxorubicin Phase 1b SGC data | 17-Dec-2025 | 07:00 | RNS |
| Preliminary Data in Faridoxorubicin Phase 1b Trial | 08-Dec-2025 | 07:00 | RNS |
| Completion of Placing and TVR | 03-Nov-2025 | 08:24 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 57.71p |
| Change Today | -0.29p |
| % Change | -0.49 % |
| 52 Week High | 82.50 |
| 52 Week Low | 27.50 |
| Volume | 207,638 |
| Shares Issued | 436.45m |
| Market Cap | £251.89m |
| Beta | 0.83 |
| RiskGrade | 461 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| Time | Volume / Share Price |
| 08:45 | 5,000 @ 59.25p |
| 08:40 | 15,000 @ 57.75p |
| 08:39 | 25,000 @ 58.91p |
| 08:39 | 5,000 @ 58.88p |
| 08:36 | 16 @ 59.96p |
You are here: research